- Home
- TTNP vs ATNF Comparison
TTNP vs ATNF Comparison
Compare TTNP & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- ATNF
- Stock Information
- Founded
- TTNP 1991
- ATNF 2016
- Country
- TTNP United States
- ATNF United States
- Employees
- TTNP N/A
- ATNF N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- ATNF Health Care
- Exchange
- TTNP Nasdaq
- ATNF Nasdaq
- Market Cap
- TTNP 3.4M
- ATNF 3.8M
- IPO Year
- TTNP 1996
- ATNF N/A
- Fundamental
- Price
- TTNP $4.65
- ATNF $1.05
- Analyst Decision
- TTNP
- ATNF
- Analyst Count
- TTNP 0
- ATNF 0
- Target Price
- TTNP N/A
- ATNF N/A
- AVG Volume (30 Days)
- TTNP 81.0K
- ATNF 43.3K
- Earning Date
- TTNP 05-14-2025
- ATNF 05-15-2025
- Dividend Yield
- TTNP N/A
- ATNF N/A
- EPS Growth
- TTNP N/A
- ATNF N/A
- EPS
- TTNP N/A
- ATNF N/A
- Revenue
- TTNP N/A
- ATNF N/A
- Revenue This Year
- TTNP N/A
- ATNF N/A
- Revenue Next Year
- TTNP N/A
- ATNF N/A
- P/E Ratio
- TTNP N/A
- ATNF N/A
- Revenue Growth
- TTNP N/A
- ATNF N/A
- 52 Week Low
- TTNP $3.03
- ATNF $0.66
- 52 Week High
- TTNP $14.80
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- TTNP 53.37
- ATNF 49.77
- Support Level
- TTNP $4.16
- ATNF $1.01
- Resistance Level
- TTNP $5.12
- ATNF $1.10
- Average True Range (ATR)
- TTNP 0.44
- ATNF 0.08
- MACD
- TTNP -0.01
- ATNF -0.01
- Stochastic Oscillator
- TTNP 51.54
- ATNF 35.29
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.